CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$22.50
arrow_upward
+1.43%(+0.32) 1D
Nov 13, 10:49:37 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
$22.50
High
$23.13
Low
$22.36
Mkt. cap
12.06T
Avg. vol.
372.86K
Volume
49.03K
52-wk high
$34.84
52-wk low
$18.33
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
Open
$22.50
High
$23.13
Low
$22.36
Mkt. cap
12.06T
Avg. vol.
372.86K
Volume
49.03K
52-wk high
$34.84
52-wk low
$18.33
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
24/7 Wall St.
·
57 minutes ago
S&P 500 Opens Lower as Tech Selloff Splits the Market
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitechugai-pharm.co.jp